Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
Approved and Donation Ready
This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.
If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.Fund Type
Co-Pay, Co-insurance & Deductible (medications and office visits), Medical Insurance PremiumsMaximum Award Level
$1,500 Per Year
- Household Income Requirements 300% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements All Insurance Types
- Must reside and receive treatment in the United States.
Hyperlipidemia is an umbrella term that refers to any of several acquired or genetic disorders that result in a high level of lipids (fats, cholesterol and triglycerides) circulating in the blood, increasing the risk of developing atherosclerosis. The amount and types of fat and cholesterol in the blood are determined by a person’s genetic makeup and environmental factors. Having hyperlipidemia significantly increases the risk of developing cardiovascular disease, including coronary artery disease (heart), cerebrovascular disease (brain) and peripheral vascular disease (limbs) with age. There are six types of hyperlipidemia, Type I (hyperchylomicronemia), Type IIa (familial hypercholesterolemia) & IIb (familial combined hyperlipidemia), Type III (familial dysbetalipoproteinemia), Type IV (familial hyperlipidemia) and Type V (hypertriglyceridemia).